Related Experiment Video
Updated: Jan 17, 2026

08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
7.4K
The Critical Need to Consolidate All Gene Therapy Data in Haemophilia
Barbara Konkle1, Donna Coffin2, Cédric Hermans3
1Washington Center for Bleeding Disorders, University of Washington, Seattle, Washington, USA.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|September 16, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Bioequivalence studies: Biowaivers
229
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
229

